Kenneth E. Weg
Gründer bei Metamark Genetics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael P. Bailey | M | 58 | 14 Jahre | |
| Raju S. Kucherlapati | M | 81 |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | 22 Jahre |
| Jerry Williamson | M | - |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | 9 Jahre |
| Sandra Leung | F | 63 | 32 Jahre | |
| Christophe M. Bianchi | M | 62 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 18 Jahre |
| David Rimm | M | - |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | 17 Jahre |
| Emile Farhan | M | - | 12 Jahre | |
| Peter Blume-Jensen | M | 62 |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | 14 Jahre |
| Mansoor Mirza | M | 63 |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | 14 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Giovanni Caforio | M | 59 | 24 Jahre | |
| Tuan Ha-Ngoc | M | 72 | 13 Jahre | |
| Lamberto Andreotti | M | 73 | 19 Jahre | |
| Ken Bate | M | 73 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 20 Jahre |
| Ronald DePinho | M | 69 |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | 11 Jahre |
| Samuel Barker | M | 81 |
Clearview Projects, Inc.
| 3 Jahre |
| Deborah Dunsire | M | 61 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 8 Jahre |
| Lynda Chin | M | - |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | 5 Jahre |
| Donna M. Radzik | M | - | - | |
| Mark Levin | M | 73 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 12 Jahre |
| Henri A. Termeer | M | 78 | 6 Jahre | |
| Douglas Cole | M | 63 | 10 Jahre | |
| Kevin Starr | M | 61 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 4 Jahre |
| Anthony Evnin | M | 83 | 21 Jahre | |
| George Esgro | M | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 1 Jahre |
| Russell C. Hirsch | M | 62 | 9 Jahre | |
| Norman Selby | M | 71 |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA.
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 16 Jahre |
| Steven B. Ratoff | M | 81 | 16 Jahre | |
| Leif Valdemar Johansson | M | 73 | 13 Jahre | |
| Mark R. Straley | M | 63 |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | 2 Jahre |
| Peter F. Smith | M | 66 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | - |
| Michael Kauffman | M | 60 |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA.
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 3 Jahre |
| Arlene Morris | F | 72 |
Clearview Projects, Inc.
| 2 Jahre |
| Elan Ezickson | M | 60 | 10 Jahre | |
| Jeno Gyuris | M | 64 | 12 Jahre | |
| Joseph Squicciarino | M | 67 | 22 Jahre | |
| John E. Elicker | M | 64 | 20 Jahre | |
| Shawn M. Marcell | M | 62 |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | - |
| Suzanne Fleming | F | 63 | 8 Jahre | |
| Priya Jambhekar | F | - | 3 Jahre | |
| Gregory Critchfield | M | 72 |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | 6 Jahre |
| Charles Homcy | M | 75 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 6 Jahre |
| Lewis B. Campbell | M | 77 | 18 Jahre | |
| John Bishop | M | 62 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 4 Jahre |
| Jason Haddock | M | 54 | 14 Jahre | |
| Robert C. Young | M | 84 | 12 Jahre | |
| Nicholas G. Galakatos | M | 66 | 10 Jahre | |
| Charles Sigal | M | 72 | 16 Jahre | |
| Robert Epstein | M | 58 | 2 Jahre | |
| Matthew D. Dallas | M | 49 | 4 Jahre | |
| Anthony Hooper | M | 69 | 15 Jahre | |
| Brian Daniels | M | 65 | 14 Jahre | |
| Laurie Keating | F | 70 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 10 Jahre |
| Lawrence Hamilton | M | 66 | 8 Jahre | |
| Fabio M. Benedetti | M | 58 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 6 Jahre |
| Fouad Namouni | M | 55 | 21 Jahre | |
| Lisa Adler | F | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | - |
| Laurie Glimcher | M | 72 | 20 Jahre | |
| A. Grant Heidrich | M | 71 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 15 Jahre |
| Joseph Vittiglio | M | 52 | 8 Jahre | |
| Barry J. Wolfenson | M | 57 | 23 Jahre | |
| Gerald Bruce | M | 68 | 8 Jahre | |
| Stephen McAndrew | M | - | 8 Jahre | |
| William Sharbaugh | M | 61 | 6 Jahre | |
| Gerald Crabtree | M | 83 | 7 Jahre | |
| Emmanuel Blin | M | 54 | - | |
| Larry Mallis | M | - | - | |
| Antoine Grouès | M | - | - | |
| Kirsten Detrick | F | 59 | 13 Jahre | |
| David Ian Johnson | M | 66 | 12 Jahre | |
| Charles Rowland | M | 65 | 8 Jahre | |
| A. Collier Smyth | M | 78 | 13 Jahre | |
| Arturo O. Araya | M | 53 | 3 Jahre | |
| Paul S. Anderson | M | 85 | 1 Jahre | |
| Dinesh Patel | M | 67 | 8 Jahre | |
| William Jones | M | 60 | 12 Jahre | |
| Ronald A. Pepin | M | 68 | 10 Jahre | |
| Kin Yip Leung | M | 63 | 9 Jahre | |
| Steven E. Benner | M | 64 | 7 Jahre | |
| William T. Comer | M | 85 | 9 Jahre | |
| John L. McGoldrick | M | 83 | 10 Jahre | |
| Dean Mitchell | M | 68 | 3 Jahre | |
| Frank Perier | M | 64 | 9 Jahre | |
| James R. Ellinghausen | M | 65 | 8 Jahre | |
| David K. Bol | M | 58 | 6 Jahre | |
| Joseph C. Caldarella | M | 68 | 20 Jahre | |
| Nicholas Landekic | M | 65 | 3 Jahre | |
| Timothy McNamara | M | 67 | 9 Jahre | |
| Kenneth Anderson | M | - | 17 Jahre | |
| Luigi Lenaz | M | 83 | 19 Jahre | |
| Michael Mee | M | 81 | 7 Jahre | |
| William A. Scott | M | 84 | 6 Jahre | |
| Henry Y. Pan | M | 77 | 7 Jahre | |
| Stacey Latuche | F | - | - | |
| Andrew Bodnar | M | 75 | - | |
| Adeoye Olukotun | M | 79 | 13 Jahre | |
| Nancy Lurker | F | 66 | 14 Jahre | |
| Gary Dickinson | M | 72 | 4 Jahre | |
| Jane A. Kramer | F | 68 | 11 Jahre | |
| Mark J. Carvlin | M | - | 4 Jahre | |
| John H. Lawrence | M | - | 18 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Kenneth E. Weg
- Persönliches Netzwerk